E-LIB Suche - Ergebnisse für: Chetty, Manoranjenni

1

Design and conduct considerations for studies in patients w..:

Ravenstijn, Paulien ; Chetty, Manoranjenni ; Manchandani, Pooja...
Clinical and Translational Science. 16 (2022) 1 - p. 50-61 , 2022

Link: https://doi.org/10.1111/..

2

Potential benefit of vitamin D supplementation in people wi..:

Chetty, Vasudevan V. ; Chetty, Manoranjenni
Clinical and Translational Science. 14 (2021) 6 - p. 2111-2116 , 2021

Link: https://doi.org/10.1111/..

3

Design and conduct considerations for studies in patients w..:

Ravenstijn, Paulien ; Chetty, Manoranjenni ; Manchandani, Pooja
Clinical and Translational Science. 14 (2021) 5 - p. 1689-1704 , 2021

Link: https://doi.org/10.1111/..

4

Clopidogrel Dosing: Current Successes and Emerging Factors ..:

Chetty, Manoranjenni ; Ravenstijn, Paulien ; Manchandani, Pooja
Clinical Pharmacology & Therapeutics. 109 (2020) 5 - p. 1203-1211 , 2020

Link: https://doi.org/10.1002/..

5

Prediction of the exposure to a 400-mg daily dose of efavir..:

Chetty, Manoranjenni ; Danckwerts, Michael P. ; Julsing, Andrea
European Journal of Clinical Pharmacology. 76 (2020) 8 - p. 1143-1150 , 2020

Link: https://doi.org/10.1007/..

6

Estimation of an Appropriate Dose of Trazodone for Pediatri..:

Oggianu, Laura ; Ke, Alice B. ; Chetty, Manoranjenni...
CPT: Pharmacometrics & Systems Pharmacology. 9 (2020) 2 - p. 77-86 , 2020

Link: https://doi.org/10.1002/..

7

Are Standard Doses of Renally-Excreted Antiretrovirals in O..:

De Sousa Mendes, M. ; Chetty, Manoranjenni
Drugs in R&D. 19 (2019) 4 - p. 339-350 , 2019

Link: https://doi.org/10.1007/..

8

Physiologically based pharmacokinetic modelling to guide dr..:

Chetty, Manoranjenni ; Johnson, Trevor N. ; Polak, Sebastian...
Advanced Drug Delivery Reviews. 135 (2018) - p. 85-96 , 2018

Link: https://doi.org/10.1016/..

9

Application of Physiologically Based Pharmacokinetic (PBPK)..:

Chetty, Manoranjenni ; Cain, Theresa ; Wedagedera, Janak..
Frontiers in Pharmacology. 9 (2018) - p. , 2018

Link: https://doi.org/10.3389/..

10

Potential Sources of Inter-Subject Variability in Monoclona..:

Gill, Katherine L. ; Machavaram, Krishna K. ; Rose, Rachel H..
Clinical Pharmacokinetics. 55 (2016) 7 - p. 789-805 , 2016

Link: https://doi.org/10.1007/..

11

Prediction of the Pharmacokinetics, Pharmacodynamics, and E..:

Chetty, Manoranjenni ; Li, Linzhong ; Rose, Rachel...
Frontiers in Immunology. 5 (2015) - p. , 2015

Link: https://doi.org/10.3389/..

12

Are Physiologically Based Pharmacokinetic Models Reporting ..:

Musther, Helen ; Gill, Katherine L. ; Chetty, Manoranjenni...
The AAPS Journal. 17 (2015) 5 - p. 1268-1279 , 2015

Link: https://doi.org/10.1208/..

13

Impact of CYP polymorphisms, ethnicity and sex differences ..:

Naidoo, Panjasaram ; Chetty, Vasudevan V. ; Chetty, Manoranjenni
European Journal of Clinical Pharmacology. 70 (2014) 4 - p. 379-389 , 2014

Link: https://doi.org/10.1007/..

14

Applications of linking PBPK and PD models to predict the i..:

Chetty, Manoranjenni ; Rose, Rachel H. ; Abduljalil, Khaled...
Frontiers in Pharmacology. 5 (2014) - p. , 2014

Link: https://doi.org/10.3389/..

15

Pharmacokinetics, Pharmacodynamics and Physiologically-Base..:

Dostalek, Miroslav ; Gardner, Iain ; Gurbaxani, Brian M...
Clinical Pharmacokinetics. 52 (2013) 2 - p. 83-124 , 2013

Link: https://doi.org/10.1007/..